ghk-cu coa usa 50mg GHK-CU – Research Peptide |

95% CI, 0.303 to 0.806

When to Use CPT 90471 and When Not To Bill 90471 when giving any single injectable vaccine during a patient visit

Stay Up After Eating : Remain standing or even sitting after eating because gravity itself assists in retaining stomach acid where it belongsin the stomach

Current availability This product is currently available

HPLC analysis confirms the purity of the peptide, mass spectrometry (MS) verifies the molecular identity, and additional ICP or AAS analysis determines the copper content in the complex

Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use